SOHO Brazil 2022

https://rvmais.iweventos.com.br/site/sintoma2022

 

SOHO Brazil 2022
Avatar

SOHO Brazil 2022: Who Is a Candidate for CAR-T in DLBCL? The Window of Opportunity That Cannot Be Missed & Opportunities for the Future

By SOHO Brazil 2022 FEATURING Michael Bishop, Alvaro Alencar, Phillip Scheinberg
By SOHO Brazil 2022 FEATURING Michael Bishop, Alvaro Alencar, Phillip Scheinberg
16 views
August 31, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
Lymphoma
25:36

SOHO Brazil 2022: Are All MZLs the Same? What Do We Know About Subty…

SOHO Brazil 2022

I. Lossos, P. Scheinberg

33 views
27:08

Are We Curing Some Mantle Cell Lymphomas?

SOHO Brazil 2022

J. Chavez, A. Alencar

66 views
23:08

SOHO Brazil 2022 on Bispecifics in Follicular Lymphoma: A “Mini-Revo…

SOHO Brazil 2022

J. Chavez, A. Alencar

20 views
24:15

SOHO Brazil 2022 on CPIs in Hodgkin Lymphoma: Recent Progress

SOHO Brazil 2022

P. Armand, A. Alencar

65 views
24:28

SOHO Brazil 2022 on DLBCL: Finally Breaking the Back of R-CHOP?

SOHO Brazil 2022

C. Moskowitz, A. Alencar

86 views
23:04

SOHO Brazil 2022 on 1st Relapse in DLBCL: Induction Chemo & Autotran…

SOHO Brazil 2022

M. Bishop, P. Scheinberg

13 views
26:04

SOHO Brazil 2022 on Targeted Therapy in Indolent Lymphomas: The Role…

SOHO Brazil 2022

I. Lossos, P. Scheinberg

41 views
32:17

SOHO Brazil 2022 on Waldenstrom’s Macroglobulinemia: The More Diffic…

SOHO Brazil 2022

S. Treon, P. Scheinberg

74 views
27:03

SOHO Brazil 2022: Who Is a Candidate for CAR-T in DLBCL? The Window …

SOHO Brazil 2022

M. Bishop, A. Alencar, P. Scheinberg

16 views
36:30

SOHO Brazil 2022 Discussion: What Are the Options in Primary CNS Lym…

SOHO Brazil 2022

J. Rubenstein, A. Alencar

37 views